Living Proof Science Co. Inks New Lease at Farnsworth via CBRE for Phase 3 RE Partners
April 10, 2026
12 Farnsworth Street, Boston MA
| Boston — CBRE’s Boston Leasing team has executed a 14,085 sq. ft. lease for office and lab space at 12 Farnsworth Street in the heart of Boston’s dynamic Seaport District. Living Proof will relocate its operations from the Innovation & Design Building to the entire fifth floor of the prominent life science property owned by Phase 3 Real Estate Partners, Inc. (P3RE).move-in-ready CBRE’s Eric Smith and Lauren Drakeley are leading the leasing and marketing efforts for the property and represented building ownership in the lease negotiations. CBRE’s Tim Lahey acted on behalf of Living Proof. GENESIS 12 Farnsworth is a brick-and-beam life science property that has been fully converted from office to laboratory use as part of Phase 3 Real Estate Partners’ GENESIS platform. The completed conversion includes upgraded mechanical, electrical, and plumbing infrastructure designed to meet modern laboratory standards, along with ±14,000 RSF floor plates that support both office and R&D functions. Phase 3’s GENESIS spec program delivers move-in-ready environments tailored to tenant needs, enabling a streamlined path to occupancy for growing companies. “We completed the conversion of GENESIS 12 Farnsworth to create a ready-to-occupy life science environment that preserves the historical character of the building while delivering modern lab infrastructure,” said Morgan Weinstein, Northeast EVP at Phase 3 Real Estate Partners, Inc. (P3RE). “By offering fully built spec space in a prime Seaport location, we’re able to simplify real estate decisions so companies like Living Proof can focus on their teams, their growth, and their science.” |
